CGTX — Cognition Therapeutics Balance Sheet
0.000.00%
- $149.18m
- $109.85m
- 25
- 12
- 78
- 30
Annual balance sheet for Cognition Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 5.19 | 54.7 | 41.6 | 29.9 | 25 |
| Net Total Receivables | 1.15 | 2.27 | 3.67 | 1.28 | 2.69 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 6.91 | 59 | 47.6 | 34.2 | 29.6 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.211 | 0.145 | 1.05 | 0.941 | 0.679 |
| Other Long Term Assets | |||||
| Total Assets | 7.12 | 59.1 | 50.4 | 35.2 | 30.2 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 3.25 | 7.86 | 7.79 | 10.2 | 11.1 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 19.9 | 7.86 | 10.2 | 10.7 | 11.5 |
| Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | -12.8 | 51.3 | 40.2 | 24.5 | 18.8 |
| Total Liabilities & Shareholders' Equity | 7.12 | 59.1 | 50.4 | 35.2 | 30.2 |
| Total Common Shares Outstanding |